Aura Biosciences, Inc. (AURA) Reports In-Line Q2 EPS

Aura Biosciences, Inc. (NASDAQ: AURA) reported Q2 EPS of ($0.47), in-line with the analyst estimate of ($0.47).

For earnings history and earnings-related data on Aura Biosciences, Inc. (AURA) click here.

You May Also Be Interested In

• Goldman Sachs Adjust Monthly US Director's Cut List
• Citi cuts SK Hynix price target to KRW3,000,000 on FX pressure
• Getty Realty (GTY) Reiterated at Market Outperform by Citizens Amid Favourable Trends